✦ LIBER ✦

Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease

✍ Scribed by R. M. Kostrzewa; J. P. Kostrzewa; R. Brus

Publisher: Springer
Year: 2002
Tongue: English
Weight: 66 KB
Volume: 23
Category: Article
ISSN: 0939-4451
DOI: 10.1007/s00726-001-0110-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of 8-oxoguanine DNA glycosyla

Expression of 8-oxoguanine DNA glycosylase (OGG1) in Parkinson’s disease and related neurodegenerative disorders

✍ Jiro Fukae; Masashi Takanashi; Shin-ichiro Kubo; Ken-ichi Nishioka; Yusaku Nakab 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 401 KB

Comparison between the decrease of dopam

Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models

✍ Yasushi Ito; Masahiro Fujita; Shoichi Shimada; Yoshiyuki Watanabe; Tomoya Okada; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

Early diagnosis of Parkinson's disease (PD) is important for the potential application of neuroprotective therapies. The purpose of this study was to assess the detection of the early changes of PD by either imaging the dopamine transporter (DAT) or uptake of L-3,4-dihydroxyphenylalanine (L-DOPA). A

Activation of the extracellular signal-r

Activation of the extracellular signal-regulated kinases 1 and 2 by glial cell line-derived neurotrophic factor and its relation to neuroprotection in a mouse model of Parkinson's disease

✍ Niklas Lindgren; Rehana K. Leak; Kirsten M. Carlson; Amanda D. Smith; Michael J. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

## Abstract Glial cell line‐derived neurotrophic factor (GDNF) has been shown to be neuroprotective in animal models of the dopamine deficiency in Parkinson's disease. To examine the role of the extracellular signal‐regulated kinases 1 and 2 (ERK1/2) in this process, we infused a single dose of GDN